(Q41878553)

13 October 2017

Oestrogen and progesterone receptors in primary breast cancer: a population study (English)

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90393-R

4 December 2022

1 reference

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90393-R

4 December 2022

author name string

S. Gamulin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1827727

4 December 2022

R. Romić-Stojković

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1827727

4 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1827727

4 December 2022

publication date

1 January 1991

1 reference

full work available at URL

13 October 2017

https://api.elsevier.com/content/article/PII:027753799190393R?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90393-R

https://api.elsevier.com/content/article/PII:027753799190393R?httpAccept=text/plain

4 December 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90393-R

European Journal of Cancer

4 December 2022

published in

1 reference

13 October 2017

27

1 reference

13 October 2017

4

1 reference

13 October 2017

491-495

1 reference

The search for the causes of breast and colon cancer

13 October 2017

1

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90393-R

The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer

4 December 2022

2

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90393-R

Estrogen receptor and endocrine responsiveness in Japanese versus American breast cancer patients

4 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90393-R

Breast cancer prognosis in three different racial groups in relation to steroid hormone receptor status

4 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90393-R

Estrogen and progesterone receptor determinations in breast cancer. Technology, biology and clinical significance

4 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90393-R

Evaluation of estrogen receptor assays in human breast cancer tissue

4 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90393-R

A comparative study on estradiol receptor assays in human breast cancer tissue

4 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90393-R

Sampling and storage of breast cancer tissue for steroid receptor assays

4 December 2022

10

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90393-R

Characterization and assay of progesterone receptor in human mammary carcinoma

4 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90393-R

Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer

4 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90393-R

Steroid receptor levels in breast cancer. Relationships with age and menopausal status

4 December 2022

14

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90393-R

Multiple steroid receptors in human breast cancer. II. Estrogen and progestin receptors in 672 primary tumors

4 December 2022

15

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90393-R

Female sex steroid receptor status in primary and metastatic breast carcinoma and its relationship to serum steroid peptide hormone levels

4 December 2022

16

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90393-R

Oestrogen receptors in breast tumours: associations with age, menopausal status and epidemiological and clinical features in 735 patients

4 December 2022

17

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90393-R

The value of progesterone receptor assays in the management of advanced breast cancer

4 December 2022

20

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90393-R

Steroid-hormone receptors in breast cancer

4 December 2022

21

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90393-R

Immunological quantitation of nuclear receptors in human breast cancer: relation to cytosolic estrogen and progesterone receptors

4 December 2022

22

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90393-R

Progesterone and estrogen receptors as prognostic variables in breast cancer

4 December 2022

23

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90393-R

Correlation of estrogen and progesterone receptors with histologic differentiation in mammary carcinoma

4 December 2022

24

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90393-R

Relationship of cytosolic estrogen and progesterone receptor content and the growth fraction in human mammary carcinomas

4 December 2022

27

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90393-R

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

4 December 2022

28

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90393-R

Epidermal growth factor receptor in human breast cancers: Correlation with estrogen and progesterone receptors

4 December 2022

29

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90393-R

Genesis of breast cancer is in the premenopause

4 December 2022

30

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90393-R

4 December 2022

Identifiers

1 reference

13 October 2017

1 reference